Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine

Agents Actions. 1991 May;33(1-2):61-3. doi: 10.1007/BF01993127.

Abstract

Rat serosal mast cells were evaluated for their capacity to generate a nitric oxide-like factor by two bioassays: inhibition of platelet aggregation and stimulation of mast cell guanylate cyclase. Incubation of mast cells with human washed platelets, both treated with indomethacin, inhibited thrombin-induced platelet aggregation which was potentiated by superoxide dismutase and reversed by oxyhaemoglobin. When mast cells alone were stirred at 1000 rpm, a time dependent increase in the levels of their cGMP but not cAMP was observed. Preincubation of mast cells with NG-monomethyl-L-arginine significantly enhanced E. coli lipopolysaccharide-evoked histamine release. Our results show that mast cell histamine release can be modulated by an intrinsically generated nitric oxide-like factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Blood Platelets / drug effects
  • Blood Platelets / physiology*
  • Cyclic GMP / metabolism
  • Guanylate Cyclase / metabolism
  • Histamine Release / drug effects*
  • Humans
  • Indomethacin / pharmacology
  • Male
  • Mast Cells / drug effects
  • Mast Cells / metabolism*
  • Nitric Oxide / metabolism*
  • Nitric Oxide / pharmacology
  • Oxyhemoglobins / pharmacology
  • Platelet Aggregation / drug effects
  • Rats
  • Rats, Inbred Strains
  • Superoxide Dismutase / pharmacology
  • Thrombin / pharmacology
  • omega-N-Methylarginine

Substances

  • Oxyhemoglobins
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Superoxide Dismutase
  • Thrombin
  • Guanylate Cyclase
  • Cyclic GMP
  • Indomethacin